EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identifying the plasma metabolome responsible for mediating immune cell action in severe COVID-19: a Mendelian randomization investigation

Yixia Zhang, Jie Hua, Liang Chen

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1393432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yixia Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: COVID-19, Mendelian Randomization Analysis, Genome-Wide Association Study, Metabolome. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The immune response regulates the severity of COVID-19 (sCOVID-19). This study examined the cause-and-effect relationship between immune cell traits (ICTs) and the risk of severe COVID-19. Additionally, we discovered the potential role of plasma metabolome in modulating this risk.

Methods

Employing data from a genome-wide association study (GWAS), we conducted a two-sample Mendelian randomization (MR) assessment of 731 genetic ICTs and sCOVID-19 (5,101 cases, 1,383,241 controls) incidence. The MR analysis was utilized to further quantitate the degree of plasma metabolome-mediated regulation of immune traits in sCOVID-19.

Results

The inverse variance weighted method recognized 2 plasma metabolites (PMs) responsible for casual associations between immune cells and sCOVID-19 risk. These included Tridecenedioate (C13:1-DC) which regulated the association between CD27 on IgD- CD38br (OR 0.804, 95% CI 0.699–0.925, p = 0.002) and sCOVID-19 risk (mediated proportion: 18.7%); arginine to citrulline ratio which controlled the relationship of CD39 on monocyte (OR 1.053, 95% CI 1.013–1.094, p = 0.009) with sCOVID-19 risk (mediated proportion: -7.11%). No strong evidence that genetically predicted sCOVID-19 influenced the aforementioned immune traits.

Conclusion

In this study, we have successfully identified a cause-and-effect relationship between certain ICTs, PMs, and the likelihood of contracting severe COVID-19. Our findings can potentially improve the accuracy of COVID-19 prognostic evaluation and provide valuable insights into the underlying mechanisms of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Mendelian Randomization AnalysisGenome-Wide Association StudyMetabolomeSARS-CoV-2HumansSeverity of Illness IndexGenetic Predisposition to DiseasePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Mendelian randomizationimmune cellsmediatorplasma metabolomesevere COVID-19

Autor:innen und Institutionen

  • Department of Hematology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China.
  • Department of Gastroenterology, Jiangsu Province People's Hospital, Nanjing, China.
  • Department of Infectious Diseases, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical College of Nanjing University, Nanjing, China.

Zitieren

APA

Zhang, Y., Hua, J., & Chen, L. (2024). Identifying the plasma metabolome responsible for mediating immune cell action in severe COVID-19: a Mendelian randomization investigation. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1393432

Vancouver

Zhang Y, Hua J, Chen L. Identifying the plasma metabolome responsible for mediating immune cell action in severe COVID-19: a Mendelian randomization investigation. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1393432

BibTeX
@article{Zhang2024,
  author = {Zhang, Yixia and Hua, Jie and Chen, Liang},
  title = {Identifying the plasma metabolome responsible for mediating immune cell action in severe COVID-19: a Mendelian randomization investigation},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1393432}
}
Kostenlos starten →